InMed Pharmaceuticals Inc. Earnings Per Share Diluted

Quick Answer

InMed Pharmaceuticals Inc. reported Earnings Per Share Diluted of $8.36 (loss) per share for the year ending 2025.

  • InMed Pharmaceuticals Inc. showed an increase of +58.5% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from InMed Pharmaceuticals Inc.'s annual report (Form 10-K), filed with the SEC on September 23, 2025.
  • XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2021 to 2025), InMed Pharmaceuticals Inc.'s Earnings Per Share Diluted has grown by 78.0%.
  • Historical annual values: Fiscal year 2025: $8.36 (loss) per share | Fiscal year 2024: $20.14 (loss) per share | Fiscal year 2023: $3.25 (loss) per share | Fiscal year 2022: $33.17 (loss) per share | Fiscal year 2021: $37.96 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: